Research & Intelligence
Peptide research, curated for practitioners.
Curated research, clinical studies, and regulatory updates from the Annular team. Published weekly. Reviewed for clinical relevance.
Research Articles
0
Clinical Studies
0
New this week
0
RESEARCH ASSISTANT
Ask the research assistant
Get answers from curated research instantly.
This Week’s Intelligence
Featured research
RESEARCH
Methylene-Blue
Real-world EHR data comparing MB vs hydroxocobalamin in septic shock supports MB as a viable adjunctive option when standard vasopressors fall short.
Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.
Proc (Bayl Univ Med Cent)
Aug 1, 2026
Read study →
REGULATORY
NMN
EFSA confirms NMN safe up to 300 mg/day; converts 1:1 to nicotinamide, well below the 900 mg upper limit.
Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide...
EFSA J
May 1, 2026
Read study →
CLINICAL STUDY
BPC-157
Pilot IV BPC-157 data in humans showed no serious adverse events, offering early tolerability context for clinical conversations.
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.
Alternative therapies in health and medicine
Sep 1, 2025
Read study →
Browse by Product
Research by compound
BPC 157 | Optimal
40 articles
→
TB-4 Frag | Heal
21 articles
→
GHK-Cu | Protect & Regenerate
54 articles
→
Methylene Blue | Energy & Cognition
35 articles
→
CJC-1295/IPA
12 articles
→
NMN | Energy Support
73 articles
→
Dihexa | Cognition
8 articles
→
KPV | Immunity
17 articles
→
SLU-PP-332 | Endurance
6 articles
→
All Research
Browse the full feed
Research Assistant
This assistant searches published scientific literature and regulatory news.
Responses are for informational purposes only and do not replace independent
clinical judgment.